Entero Healthcare Solutions
NSE: ENTERO · ISIN INE010601016 · Healthcare
₹2,064.80+39.40 (+1.95%)
Monday 9 November, 12:19 IST. Delayed. Source: Yahoo Finance.
Price chart
₹2,064.80 +39.40 (+1.95%) today
The day
- Previous close
- ₹2,025.40
- Open
- ₹2,040.10
- Day high
- ₹2,079.50
- Day low
- ₹1,965.60
Listed on NSE since 16 February 2024.
Key numbers
- Market value
- ₹8,995.55 Cr
- P/E (trailing)
- 68.83
- EPS (trailing)
- ₹30.00
- Price to book
- 5.32
- Dividend yield
- 0.00%
- Debt to equity
- 0.39
- Profit margin
- 1.8%
- Beta
- -0.32
- Volume today
- 4.42 L
- Average volume
- 3.10 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹3,293.14 Cr | ₹-11.56 Cr |
| FY24 | ₹3,888.16 Cr | ₹39.11 Cr |
| FY25 | ₹5,065.48 Cr | ₹94.82 Cr |
| FY26 | ₹6,540.06 Cr | ₹115.04 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹2,087 Cr | ₹46 Cr | +44.1% |
| Q1 FY27Apr–Jun 2026 | ₹1,940 Cr | ₹38 Cr | +37.3% |
| Q4 FY26Jan–Mar 2026Audited | ₹1,910 Cr | ₹28 Cr | +9.0% |
| Q3 FY26Oct–Dec 2025 | ₹1,707 Cr | ₹28 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹1,571 Cr | ₹32 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹1,404 Cr | ₹28 Cr | – |
Source: Entero Healthcare Solutions’s results filed with NSE, consolidated (the whole group). Net profit is the share of Entero Healthcare Solutions’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹211 Cr | ₹103 Cr |
| Investments | ₹127 Cr | ₹130 Cr |
| Inventories | ₹867 Cr | ₹842 Cr |
| Owed by customers | ₹1,461 Cr | ₹1,212 Cr |
| Cash and equivalents | ₹96 Cr | ₹147 Cr |
| Total assets | ₹3,871 Cr | ₹3,600 Cr |
| Borrowings | ₹794 Cr | ₹567 Cr |
| Total liabilities | ₹1,997 Cr | ₹1,848 Cr |
| Shareholders’ equity | ₹1,781 Cr | ₹1,689 Cr |
Source: Entero Healthcare Solutions’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Entero Healthcare Solutions
Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products in India. The company offers a range of pharmaceuticals and other healthcare products to retail pharmacies and healthcare practitioners; and healthcare products, including pharmaceutical and nutraceutical products and vaccines; medical devices, such as orthopaedic implants and coronary stents; and hospital consumables comprising examination and surgical gloves, syringes, needles, and sutures to hospitals and clinics. It also provides private label products under the Entero Surgicals private label, such as monitoring devices, nursing and rehabilitation products, and consumables; commercial solutions; and healthcare product distribution solutions, including imports, central warehousing, redistribution, last mile delivery, and connection with the pharmacies, hospitals, and clinics. The company was incorporated in 2018 and is based in Mumbai, India.
- Industry
- Medical Distribution
- Based in
- Mumbai
- Employees
- 4,671
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Entero Healthcare Solutions in the last day or two.
Dividends and corporate actions
All companiesNSE lists no dividends or other corporate actions for Entero Healthcare Solutions.
Information only, not investment advice. Prices are delayed.